NCT06599853 Fever Education Given to Parents of Children Presenting to the Emergency Department With Fever
| NCT ID | NCT06599853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Merve YETİMOĞLU |
| Condition | Fever |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-04-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fever is a common symptom of childhood, especially between the ages of one and five, and is the main reason for emergency room visits. These emergency room visits are due to parents incorrect information and practices regarding fever management. This situation causes an increase in parental anxiety and failure to provide fever management. In line with this information, this study was planned to evaluate the effects of education given to parents of children presenting to the emergency room with fever on parental anxiety level and fever management.
Eligibility Criteria
Inclusion Criteria: * Having a child between the ages of 1-5 * Able to read, understand and have no problems speaking Turkish * Having a green triage code in the emergency room triage application Exclusion Criteria: * Children diagnosed with or receiving treatment for chronic diseases * Children with a history of febrile convulsions * Children dependent on home mechanical ventilation * Parents with psychiatric diagnoses will be excluded from the study
Contact & Investigator
Merve YETİMOĞLU, Nursing
PRINCIPAL INVESTIGATOR
Karadeniz Technical University
Frequently Asked Questions
Who can join the NCT06599853 clinical trial?
This trial is open to participants of all sexes, studying Fever. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06599853 currently recruiting?
Yes, NCT06599853 is actively recruiting participants. Contact the research team at merveyetimoglu0@gmail.com for enrollment information.
Where is the NCT06599853 trial being conducted?
This trial is being conducted at Trabzon, Turkey (Türkiye), Trabzon, Turkey (Türkiye), Trabzon, Turkey (Türkiye).
Who is sponsoring the NCT06599853 clinical trial?
NCT06599853 is sponsored by Merve YETİMOĞLU. The principal investigator is Merve YETİMOĞLU, Nursing at Karadeniz Technical University. The trial plans to enroll 80 participants.